Mark Cuban, cofounder of Cost Plus Drugs, stated that potential tariffs on pharmaceuticals imported from India would compel the company to increase medication prices. Despite having a transparent pricing model that minimizes costs for consumers, Cuban noted that they wouldn't be able to absorb any tariff costs. Currently, consumers pay a 15% markup along with additional fees for labor and shipping. The U.S. and India are in ongoing trade discussions, and Cuban highlighted the immediate financial impact of tariffs on drug pricing for consumers.
Cost Plus Drugs shoppers could feel the effects of future tariffs in their wallets. Cuban warned that any potential tariff on goods from India will force a price increase.
Cuban emphasized that if tariffs are implemented, Cost Plus Drugs will be transparent with consumers about the direct costs and broker fees, passing them directly to customers.
Mark Cuban stated, "If you only have a 15% markup and there's a 25% tariff, we'd have to lose money on every single medication."
Cuban, during his podcast appearance, noted, "We won't have a choice" if tariffs on India are implemented, risking increased medication prices.
Collection
[
|
...
]